Advanced Vaccination Technologies for Infectious and Chronic Diseases

Professor Vasso Apostolopoulos is a Distinguished Professor at RMIT University, Australia. She received her PhD in immunology in 1995 from the University of Melbourne and the Advanced Certificate in Protein Crystallography from Birkbeck College, University of London. Professor Vasso Apostolopoulos is a world-renowned researcher who has been recognized with over 100 awards for the outstanding results of her research. She has published over 500 research publications, 8 books, and 33 book chapters, is a sought-after keynote speaker at conferences, is an inventor on 21 patents, and has over 22,000 citations.Dr. Lalitkumar K. Vora is a Lecturer at the School of Pharmacy, Queen’s University, Belfast, and was included in Stanford's top 2% of world scientists list in 2023. Vivek P. Chavda is an Assistant Professor (Selection Grade) in the Department of Pharmaceutics and Pharmaceutical Technology at L. M. College of Pharmacy, Ahmedabad, Gujarat, India. He earned Bachelor and Master of Pharmacy degrees and was a Gold Medallist at Gujarat Technological University. Before entering academia, he spent several years in the Biologics industry, contributing to R&D and regulatory filings for biologics. His scholarly output includes numerous peer‑reviewed articles, several books and book chapters, and ongoing writings in newsletters. His research spans the development of biologics processes and formulations, medical device development, nano diagnostics and noncarrier formulations, long-acting parenteral formulations, and nano vaccines. He also has patent assets in development and a record of industry-focused publications.

• 1: History of Vaccination2: Vaccine Adjuvants and carriers3: Conventional vaccination methods: Inactivated and Live attenuated vaccines4: Subunit protein based Vaccines5: Peptide based vaccines and altered peptide ligands: Multiple Sclerosis paving the way6: Vector based vaccine delivery and associated immunity: Current Status and Way Forward7: It’s all about the delivery: How to augment the efficiency of DNA vaccination8: Plant-based biotechnological vaccines for emerging infectious diseases9: Expression system and purification process for the vaccine production10: Targeting dendritic cells for antigen delivery for vaccine design11: Parenteral Vaccine delivery: from basic principles to new developments12: Mucosal Vaccine delivery13: Personalized vaccines, novel vaccination technologies and future prospects14: The application of nanoparticle-based delivery systems in vaccine development15: Preclinical and clinical development for vaccines and formulations16: Regulatory processes involved in clinical trials and IPR around vaccine development17: Vaccine safety, efficacy, and ethical considerations18: Regulatory consideration and pathways for vaccine development19: New approaches to vaccines for infectious diseases20: New approaches to vaccines for cancer21: New approaches to vaccines for autoimmunity22: The fast-track development COVID-19 vaccines23: Myths and Facts about Vaccination: Dispelling Myths and Misconceptions with Science24: Proteogenomics and immunopeptidomics in the development of advanced vaccines25: Future Vaccine Technologies